Tectonic Therapeutic, Inc. (TECX) income statement
TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$21.04+0.96 (+4.78%)
Close on Nov 18, 2026Market cap $411.32MP/E –Yield 0.00%
Tectonic Therapeutic, Inc. financial ratios
See a number that looks wrong?